Your browser doesn't support javascript.
loading
Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Correlative Analysis of the CALGB 40601 and PAMELA Trials.
Fernandez-Martinez, Aranzazu; Pascual, Tomás; Singh, Baljit; Nuciforo, Paolo; Rashid, Naim U; Ballman, Karla V; Campbell, Jordan D; Hoadley, Katherine A; Spears, Patricia A; Pare, Laia; Brasó-Maristany, Fara; Chic, Nuria; Krop, Ian; Partridge, Ann; Cortés, Javier; Llombart-Cussac, Antonio; Prat, Aleix; Perou, Charles M; Carey, Lisa A.
Afiliación
  • Fernandez-Martinez A; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
  • Pascual T; Department of Genetics, University of North Carolina, Chapel Hill.
  • Singh B; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
  • Nuciforo P; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Rashid NU; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Ballman KV; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain.
  • Campbell JD; Department of Pathology, White Plains Hospital, White Plains, New York.
  • Hoadley KA; Molecular Oncology Laboratory, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Spears PA; Department of Biostatistics, University of North Carolina, Chapel Hill.
  • Pare L; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota.
  • Brasó-Maristany F; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota.
  • Chic N; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
  • Krop I; Department of Genetics, University of North Carolina, Chapel Hill.
  • Partridge A; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
  • Cortés J; Reveal Genomics, Barcelona, Spain.
  • Llombart-Cussac A; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Prat A; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Perou CM; Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Carey LA; SOLTI Breast Cancer Cooperative Group, Barcelona, Spain.
JAMA Oncol ; 9(4): 490-499, 2023 04 01.
Article en En | MEDLINE | ID: mdl-36602784
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Linfocitos Infiltrantes de Tumor / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Linfocitos Infiltrantes de Tumor / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos